A key mechanism involves the chronic inflammatory tumor microenvironment, where malignant B cells and stromal components release cytokines (e.g., IL-6, TNF-α), chemokines, ROS, and growth factors [32,33]. This evidence concerns the gene IL6 and neoplasm.